Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPF

NEXT STORY
Orion Corporation’s financial reporting and Annual General Meeting in 2020
PREV STORY
Immuron Announces Proposed Public Offering of ADSs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Genomic Medicine Market – Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Application, By End User, By Region

author_avatar
NASDAQ Market News

Leap Therapeutics Reports Second Quarter 2017 Financial Results

CAMBRIDGE, Mass., Aug. 11, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...

author_avatar
NASDAQ Market News

Athenex Announces Positive Recommendation by the Drug Safety Monitoring Board Upon the Second Interim Analysis and to Continue the Oraxol Phase III Program

BUFFALO, N.Y., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical ...

author_avatar
NASDAQ Market News